Open-Label Extension Study to Evaluate the Safety, Tolerability and Activity of Oral Fampridine-SR Tablets in Multiple Sclerosis Patients Who Participated in the MS-F203 Trial
Public ClinicalTrials.gov record NCT00648908. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Phase 3 Open-Label Extension Study to Evaluate the Safety, Tolerability and Activity of Oral Fampridine-SR in Subjects With Multiple Sclerosis Who Participated in the MS-F203 Trial
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purpose of this study is to evaluate the safety, tolerability and activity of Fampridine-SR when administered for up to 36 additional months, or until it becomes commercially available whichever comes first, in subjects who previously participated in Acorda Therapeutics Protocol MS-F203.
Study identification
- NCT ID
- NCT00648908
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 269 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years to 70 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jun 2006 (Type not available)
- Primary completion
- Jan 2011 (Actual)
- Completion
- Apr 2011 (Actual)
- Last update posted
- Feb 27, 2012
2006 – 2011
United States locations
- U.S. sites
- 27
- U.S. states
- 19
- U.S. cities
- 27
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Barrow Neurology Clinic, St. Joseph's Hospital and Medical Center | Phoenix | Arizona | 85013 | — |
| USC, Keck School of Medicine Health Care Consultation Center | Los Angeles | California | 90033 | — |
| UC Davis | Sacramento | California | 95817 | — |
| Shepherd Center | Atlanta | Georgia | 30309 | — |
| University of Chicago | Chicago | Illinois | 60637 | — |
| Indiana University MS Center | Indianapolis | Indiana | 46202 | — |
| Maryland Center for MS | Baltimore | Maryland | 21201 | — |
| Wayne State University, Department of Neurology | Detroit | Michigan | 48201 | — |
| The Schapiro Center for MS | Golden Valley | Minnesota | 55422 | — |
| Washington University School of Medicine, Div. of Rehab/Neurology | St Louis | Missouri | 63110 | — |
| Advanced Neurology Specialists | Great Falls | Montana | 59405 | — |
| Gimbel MS Center at Holy Name Hospital | Teaneck | New Jersey | 07666 | — |
| Maimonides MS Care Center | Brooklyn | New York | 11219 | — |
| Corinne Goldsmith Dickinson Center for MS | New York | New York | 10029 | — |
| University of Rochester | Rochester | New York | 14642 | — |
| SUNY Stony Brook | Stony Brook | New York | 11794 | — |
| CMC - Neuroscience & Spine Institute, Division of Neurology | Charlotte | North Carolina | 28207 | — |
| Raleigh Neurology Associates | Raleigh | North Carolina | 27607 | — |
| Cleveland Clinic Foundation | Cleveland | Ohio | 44195 | — |
| Ohio State University MS Center | Columbus | Ohio | 43221 | — |
| Oregon Health & Science University, MS Center of Oregon, UHS-42 | Portland | Oregon | 97239 | — |
| Thomas Jefferson University Physicians | Philadelphia | Pennsylvania | 19107 | — |
| Allegheny General Hospital, Allegheny Neurological Associates | Pittsburgh | Pennsylvania | 15212 | — |
| University of Texas-Houston | Houston | Texas | 77030 | — |
| Neurological Research Center, Inc. | Bennington | Vermont | 05201 | — |
| Fletcher Allen Health Care | Burlington | Vermont | 05401 | — |
| MS Center at Evergreen | Kirkland | Washington | 98034 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 5 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00648908, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Feb 27, 2012 · Synced Oct 20, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT00648908 live on ClinicalTrials.gov.